EMA: Update of the Annex to the Excipients Guideline
Recommendation

Thursday, 3 September 2026 9 .00 - 17.00 h
Establishment, Use and Maintenance of Analytical Reference Substances
In April 2024, the fourth revision of the Annex to the Guideline "Excipients in the labeling and package leaflet of medicinal products for human use" was published on the EMA website. The guideline, which has been available in the currently applicable version since March 2018, consists of the following chapters:
- INTRODUCTION
- PURPOSE
- DEFINITIONS AND EXAMPLES
- NOMENCLATURE
- EXCIPIENTS IN THE LABELLING
- EXCIPIENTS IN THE PACKAGE LEAFLET
- ANNEX: EXCIPIENTS AND INFORMATION FOR THE PACKAGE LEAFLET
Now the annex "EXCIPIENTS AND INFORMATION FOR THE PACKAGE LEAFLET" has been revised again and the information for polysorbates has been listed. The substances are listed in the annex in tabular and alphabetical order and the corresponding texts for the package leaflet are given. Furthermore, additional comments as well as the type of application and the corresponding threshold values are listed together with the update date.
The current version of the guideline "Excipients in the labeling and package leaflet of medicinal products for human use" and the "ANNEX: EXCIPIENTS AND INFORMATION FOR THE PACKAGE LEAFLET" can be found on the EMA website.
Related GMP News
06.07.2026GMP for Active Substances - What are the fundamental Requirements of the ICH Q7 Guideline? - Part 1
10.06.2026What are the Requirements for Testing for Impurities in the Pharmaceutical Industry?
03.06.2026Recycled Solvents: To use or not to use?
13.05.2026How are Reference Standards used in the Pharmaceutical Industry?
06.05.2026FDA: New Draft Guidance on Impurities in Antibiotics


